These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 17466004)
21. The contribution of rapid KATP channel gene mutation analysis to the clinical management of children with congenital hyperinsulinism. Banerjee I; Skae M; Flanagan SE; Rigby L; Patel L; Didi M; Blair J; Ehtisham S; Ellard S; Cosgrove KE; Dunne MJ; Clayton PE Eur J Endocrinol; 2011 May; 164(5):733-40. PubMed ID: 21378087 [TBL] [Abstract][Full Text] [Related]
22. Molecular and immunohistochemical analyses of the focal form of congenital hyperinsulinism. Suchi M; MacMullen CM; Thornton PS; Adzick NS; Ganguly A; Ruchelli ED; Stanley CA Mod Pathol; 2006 Jan; 19(1):122-9. PubMed ID: 16357843 [TBL] [Abstract][Full Text] [Related]
24. KATP channel mutations in congenital hyperinsulinism. Saint-Martin C; Arnoux JB; de Lonlay P; Bellanné-Chantelot C Semin Pediatr Surg; 2011 Feb; 20(1):18-22. PubMed ID: 21185999 [TBL] [Abstract][Full Text] [Related]
25. An ABCC8 gene mutation and mosaic uniparental isodisomy resulting in atypical diffuse congenital hyperinsulinism. Hussain K; Flanagan SE; Smith VV; Ashworth M; Day M; Pierro A; Ellard S Diabetes; 2008 Jan; 57(1):259-63. PubMed ID: 17942822 [TBL] [Abstract][Full Text] [Related]
26. A novel mutation associated with congenital hyperinsulinism. Natarajan G; Aggarwal S; Merritt TA Am J Perinatol; 2007 Aug; 24(7):401-4. PubMed ID: 17597441 [TBL] [Abstract][Full Text] [Related]
27. Mutations in the genes encoding the pancreatic beta-cell KATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) in diabetes mellitus and hyperinsulinism. Gloyn AL; Siddiqui J; Ellard S Hum Mutat; 2006 Mar; 27(3):220-31. PubMed ID: 16416420 [TBL] [Abstract][Full Text] [Related]
28. The Knudson's two-hit model and timing of somatic mutation may account for the phenotypic diversity of focal congenital hyperinsulinism. Giurgea I; Sempoux C; Bellanné-Chantelot C; Ribeiro M; Hubert L; Boddaert N; Saudubray JM; Robert JJ; Brunelle F; Rahier J; Jaubert F; Nihoul-Fékété C; de Lonlay P J Clin Endocrinol Metab; 2006 Oct; 91(10):4118-23. PubMed ID: 16882742 [TBL] [Abstract][Full Text] [Related]
29. Sulfonylurea receptor 1 mutations that cause opposite insulin secretion defects with chemical chaperone exposure. Pratt EB; Yan FF; Gay JW; Stanley CA; Shyng SL J Biol Chem; 2009 Mar; 284(12):7951-9. PubMed ID: 19151370 [TBL] [Abstract][Full Text] [Related]
30. Congenital hyperinsulinism due to a compound heterozygous ABCC8 mutation with spontaneous resolution at eight weeks. Kumaran A; Kapoor RR; Flanagan SE; Ellard S; Hussain K Horm Res Paediatr; 2010; 73(4):287-92. PubMed ID: 20215776 [TBL] [Abstract][Full Text] [Related]
31. Diazoxide-unresponsive congenital hyperinsulinism in children with dominant mutations of the β-cell sulfonylurea receptor SUR1. Macmullen CM; Zhou Q; Snider KE; Tewson PH; Becker SA; Aziz AR; Ganguly A; Shyng SL; Stanley CA Diabetes; 2011 Jun; 60(6):1797-804. PubMed ID: 21536946 [TBL] [Abstract][Full Text] [Related]
32. In vitro recovery of ATP-sensitive potassium channels in β-cells from patients with congenital hyperinsulinism of infancy. Powell PD; Bellanné-Chantelot C; Flanagan SE; Ellard S; Rooman R; Hussain K; Skae M; Clayton P; de Lonlay P; Dunne MJ; Cosgrove KE Diabetes; 2011 Apr; 60(4):1223-8. PubMed ID: 21411514 [TBL] [Abstract][Full Text] [Related]
33. Clinical characteristics and biochemical mechanisms of congenital hyperinsulinism associated with dominant KATP channel mutations. Pinney SE; MacMullen C; Becker S; Lin YW; Hanna C; Thornton P; Ganguly A; Shyng SL; Stanley CA J Clin Invest; 2008 Aug; 118(8):2877-86. PubMed ID: 18596924 [TBL] [Abstract][Full Text] [Related]
34. Clinical characteristics of recessive and dominant congenital hyperinsulinism due to mutation(s) in the ABCC8/KCNJ11 genes encoding the ATP-sensitive potasium channel in the pancreatic beta cell. Oçal G; Flanagan SE; Hacihamdioğlu B; Berberoğlu M; Siklar Z; Ellard S; Savas Erdeve S; Okulu E; Akin IM; Atasay B; Arsan S; Yağmurlu A J Pediatr Endocrinol Metab; 2011; 24(11-12):1019-23. PubMed ID: 22308858 [TBL] [Abstract][Full Text] [Related]
35. Mosaic paternal uniparental isodisomy and an ABCC8 gene mutation in a patient with permanent neonatal diabetes and hemihypertrophy. Shield JP; Flanagan SE; Mackay DJ; Harries LW; Proks P; Girard C; Ashcroft FM; Temple IK; Ellard S Diabetes; 2008 Jan; 57(1):255-8. PubMed ID: 17942821 [TBL] [Abstract][Full Text] [Related]
36. Clinical and molecular characterisation of 300 patients with congenital hyperinsulinism. Kapoor RR; Flanagan SE; Arya VB; Shield JP; Ellard S; Hussain K Eur J Endocrinol; 2013 Apr; 168(4):557-64. PubMed ID: 23345197 [TBL] [Abstract][Full Text] [Related]
37. Identification of a familial hyperinsulinism-causing mutation in the sulfonylurea receptor 1 that prevents normal trafficking and function of KATP channels. Taschenberger G; Mougey A; Shen S; Lester LB; LaFranchi S; Shyng SL J Biol Chem; 2002 May; 277(19):17139-46. PubMed ID: 11867634 [TBL] [Abstract][Full Text] [Related]